A multilocus genotyping assay for candidate markers of cardiovascular disease risk - Wikidata - awgldk - TriplyDB

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

http://www.wikidata.org/entity/Q35024990

about

Lipoprotein genotype and conserved pathway for exceptional longevity in humans Genetic variation in candidate osteoporosis genes, bone mineral density, and fracture risk: the study of osteoporotic fractures An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes Functional epistatic interaction between rs6046G>A in F7 and rs5355C>T in SELE modifies systolic blood pressure levels Epistatic study reveals two genetic interactions in blood pressure regulation.Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q Search for haplotype interactions that influence susceptibility to type 1 diabetes, through use of unphased genotype data.Buffering mechanisms in aging: a systems approach toward uncovering the genetic component of aging.Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis.Effects of interacting networks of cardiovascular risk genes on the risk of type 2 diabetes mellitus (the CODAM study).New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.The M235T polymorphism in the AGT gene and CHD risk: evidence of a Hardy-Weinberg equilibrium violation and publication bias in a meta-analysis.Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: dat Association of congenital cardiovascular malformations with 33 single nucleotide polymorphisms of selected cardiovascular disease-related genes A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women.Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.Association of CVD candidate gene polymorphisms with ischemic stroke and cerebral hemorrhage in Chinese individuals Angiotensin I-converting enzyme: genotype and disease associations.The predictive power of haplotypes in clinical response.Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans.Using a multi-staged strategy based on machine learning and mathematical modeling to predict genotype-phenotype risk patterns in diabetic kidney disease: a prospective case-control cohort analysis.Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes.Invited review: Identifying new mouse models of cardiovascular disease: a review of high-throughput screens of mutagenized and inbred strains.Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease.Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).Genetic polymorphisms and cerebral palsy in very preterm infants.Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women.Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a case-cohort study and meta-analyses Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease Brain-derived neurotrophic factor (BDNF) gene: a gender-specific role in cognitive function during normal cognitive aging of the MEMO-Study?Acute and chronic effects of resistance exercise on blood pressure in elderly women and the possible influence of ACE I/D polymorphism Polymorphisms in the renin-angiotensin system and migraine in women

P2860

Q21146060-BB1CB652-8564-4C2D-BB97-2BC3DB3E55C8 Q24289507-8074E881-BBA4-4C04-876E-4EFF1ABE776D Q24804221-C5FA321F-5871-4C88-8948-8BC0C9FD6947 Q28365985-ED2CD176-C193-49EE-BCC6-6392F5969E65 Q28729063-22160150-35A1-4599-833F-F10C2DA33EBF Q30425631-E6049BB6-D7D6-4290-979B-8D6C4CB1BCBB Q30486850-29D8DAB9-91F4-4E0C-B586-DBB62E18BD64 Q33195345-68BDDCC2-F0E3-4E58-9DD8-DFC6C092EF56 Q33296879-F6185811-C2B8-4CAA-A7F0-EE5487D99BE9 Q33318443-14ABB78C-5892-4ACB-97A6-1CF45A4867B1 Q33330511-6E201B4E-03E7-4F13-9C5A-495BC756B2BC Q33338981-85A14D64-F7B4-416D-818C-C8ED6A3A96B8 Q33346323-25E75557-3D05-4E32-92F9-45A59902A89F Q33424203-4194A825-BA1B-4C7A-BDE0-EFB23F8E2CC0 Q33801304-EB4F3B17-4C5E-4738-9179-488B8DE66410 Q33904720-29AA0653-BB3C-4617-8660-0CC3EE0FFA8D Q33925703-5E23F95F-4FB9-4466-82F0-3F9EC6B72905 Q34024542-F7E287FE-9633-4195-8502-1D085629F505 Q34038082-F41092BC-50CC-4E2D-B81C-48673DAFECA5 Q34075575-C34735B7-84DE-4C29-8BDC-FE92C8A4B2DB Q34169059-8C6555DD-D87E-4259-8A67-0920D63EFC61 Q34189871-B4377928-24B5-4756-9E22-37FBBED4E721 Q34212370-6A49AEAC-AD44-453C-B194-8199EAC861DC Q34509923-340EDBBC-1375-43D9-9246-BBDDBF3138DD Q34572419-89C672A5-0905-4F23-B931-C3099D1134C2 Q34859942-C773AE7D-84E3-4466-B76F-E3A581DF0340 Q34969614-F17D4D35-C5F1-450B-95E8-9F7F363B3069 Q35081497-81A26337-23F1-4CC2-8AFD-2C7525D918DB Q35231847-9B68C803-768C-4CFC-9B91-51B7A8C49E8E Q35595865-64C1CDDD-503D-431E-85F8-0E42A5528F54 Q35886165-72F30046-3664-42A1-B39A-A7CAF372A835 Q35953241-AA2FF4B5-9DC7-4DFB-BEF2-EB0F9FF0CBFA Q36046675-315B4C78-5134-407F-A996-C5C627341D42 Q36661117-15CA902E-9CFA-4939-A00A-72C1A902B77C Q36786622-30637016-CF2E-46A4-8F9C-45CB7B332F69 Q36812818-E5869CEC-8EF3-47E5-9955-FAC4459E56A1 Q36925334-1E8B9138-4144-4B85-B580-2A7CDD154967 Q36927469-87E4D5F3-0946-4F6D-9D3B-31B2F3C2F930 Q37027518-2AA1EB8A-B0E9-4F4A-9DFA-04D328233D7A Q37102338-AEC6A60C-DEFB-44E8-8A14-B09FB160B0F4

P2860

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

http://www.wikidata.org/entity/Q35024990

description

1999 nî lūn-bûn

@nan

1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

@ast

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

@en

type

label

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

@ast

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

@en

prefLabel

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

@ast

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

@en

P1433

Q35024990-9C02F94C-674A-46F5-9BCC-DC5AE32274AC

P1476

Q35024990-4AEC3EAF-4C37-412C-B176-D8E357C84F07

P2093

Q35024990-042E9C0D-C224-438E-B39F-D48E5E588158

Q35024990-3E83ABBF-D1C2-433F-899F-2AFF5466159A

Q35024990-4BF27536-FFA5-49CD-B6E4-5CC53181AF33

Q35024990-53725CA3-ED18-4710-8C3B-EF173CDE4FC6

Q35024990-5997153C-CE06-45B6-AB53-97C1CD3C58E1

Q35024990-7D2724ED-4A7F-432C-8CF5-F0EE03B27295

Q35024990-A29F2D5C-19B7-4336-8CE6-B30745A2CFCF

Q35024990-DB84514A-DD16-4237-A46E-7304E795A5EC

Q35024990-F44F68B2-EF5E-4302-817A-0E872A3AB620

P2860

Q35024990-050406F7-8DEF-4A74-9AE1-2D84DBE4AF3F

Q35024990-0DF5240F-13E1-47C0-BA5A-03423DCEDA18

Q35024990-116C1452-A324-4E1E-AA79-B5C11DAF52EA

Q35024990-13F4C119-EC5D-4B80-B10A-4EDF4F98E0D9

Q35024990-1695A961-B23B-4EB5-A087-B92F75D6039C

Q35024990-18B6E3A3-6E1C-4499-97B2-5090039EAC80

Q35024990-1CC33ABE-4375-4E90-9C52-B5D6626C4C59

Q35024990-2A2F5949-85B1-4CDC-B862-4CEFCD6A4286

Q35024990-2AA5CC33-103D-44D9-ABCE-B7411D1C3D83

Q35024990-2B3DAE4D-90C0-41EC-9B1C-D69D650B4E12

P304

Q35024990-9F4DEBA0-7AB4-4552-975D-2131989992D5

P31

Q35024990-03C26288-FA6D-4765-9DC4-0C3885AFD0C1

P356

Q35024990-38DA0A67-F856-4217-B4D5-ED118AB4F738

P433

Q35024990-4A0E3532-8F7F-42C8-B50A-4E1E314F09FB

P478

Q35024990-B9A3D6FC-FADB-41BA-BD1A-0BF71CD234B5

P50

Q35024990-97628F60-9E54-4EC1-A49B-BC11FDE24A35

Q35024990-D28F61B9-65D5-49EB-92F3-7F21266E1B3F

P577

Q35024990-7D0962D2-7B73-4F9E-A9D4-FB866CCE77C7

P5875

Q35024990-E9F525F4-DBDF-4999-8E6A-6A2202B6B46B

P698

Q35024990-EBF73D21-4689-41CA-8FBA-FCF3F63506E7

P921

Q35024990-20876EF3-5F5B-4C19-A193-C34AD2A46B8A

P932

Q35024990-42C29CB7-BED4-472D-A05E-A887F0C9CB58

P356

P1433

Genome Research

P1476

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

@en

P2093

C Pallaud

http://www.w3.org/2001/XMLSchema#string

C R Pullinger

http://www.w3.org/2001/XMLSchema#string

H A Erlich

http://www.w3.org/2001/XMLSchema#string

J J Chen

http://www.w3.org/2001/XMLSchema#string

J P Kane

http://www.w3.org/2001/XMLSchema#string

M A Grow

http://www.w3.org/2001/XMLSchema#string

M J Malloy

http://www.w3.org/2001/XMLSchema#string

S Cheng

http://www.w3.org/2001/XMLSchema#string

W Klitz

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

The Interaction of Selection and Linkage. I. General Considerations; Heterotic Models.

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms

The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

A simple salting out procedure for extracting DNA from human nucleated cells

Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine beta-synthase deficiency

P304

936-949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/GR.9.10.936

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Sophie Visvikis-Siest

P577

1999-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12776074

http://www.w3.org/2001/XMLSchema#string

P698

10523522

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

310821

http://www.w3.org/2001/XMLSchema#string